Anjan Aralihalli

Anjan has over 20 years of international biopharmaceutical experience in clinical trial management, sales, marketing, operations, strategic planning and business development.

Prior to GLyPharma, he worked at ActoGeniX (acquired by Intrexon), and Shionogi Inc., where he led the $127 Million acquisition of Victory Pharma.

Between 2002-2010, he worked at Sanofi (Aventis) in both Canada and the United States in business development and strategic planning.

Prior to joining Aventis, he worked in sales and marketing at Abbott Canada. Anjan has extensive experience in dermatology, cardiovascular disease, diabetes and IBD among other therapeutic areas.

Anjan holds an MBA from Queen’s University (Montreal, Canada) a BSc from Concordia University (Montreal, Canada) and a MSc of Biotechnology from Johns Hopkins University (Baltimore, MD).